Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Chen Yu reported a 5.50% stake in Monte Rosa Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Chen Yu reported a 5.50% stake in Monte Rosa Therapeutics, Inc., 4,622,151 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 5.50%
- Shares
- 4,622,151
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP II, LLC | 2.70% | 2,311,076 |
| TCG Crossover Fund II, L.P. | 2.70% | 2,311,076 |
| TCG Crossover GP III, LLC | 2.70% | 2,311,075 |
| TCG Crossover Fund III, L.P. | 2.70% | 2,311,075 |
| Chen Yu | 5.50% | 4,622,151 |
Source
Related
- Monte Rosa Therapeutics, Inc.
- TCG Crossover GP II, LLC
- Monte Rosa Therapeutics, Inc. shareholders
- Schedule 13G · TCG Crossover GP II, LLC · Oct 17, 2025
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026